You can Subscribe to our RSS FEED:
which delivers brain tumor news and additions
to the website via RSS.
Click HERE for details on RSS.
Displaying items 1 to 25 of about 5298
Targeted Drug Combo Shows Unprecedented Activity in Some Aggressive Brain Tumors
XCELSIOR - A real time, real world learning platform for patients with advanced cancer
France allows experimental brain cancer treatment free of charge
Using Virtual Trials to Screen for Potential Glioblastoma Therapies
Musella Foundation 2021 Highlights and End of Year Appeal!
Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting
Reproducibility of clinical trials using CMV-targeted dendritic cell vaccines in patients with glioblastoma
Safety and efficacy of PVSRIPO in recurrent glioblastoma: long-term follow-up and initial multicenter results
Plus Therapeutics Announces Positive Interim Data from ReSPECT™-GBM Phase 1 Clinical Trial at the 2021 Society for Neuro-Oncology Annual Meeting
First experience with maximal safe resection and Gammatile brachytherapy as treatment for recurrent glioblastoma
DNAtrix Announces Oral Presentation of Positive Overall Survival Data with DNX-2401 in DIPG at the Society for Neuro-oncology (SNO) Annual Meeting
Presentation of XCELSIOR Observational Protocol for Real World Data Research
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting
Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
xCures presents the results of their oncology platform at the 2021 SNO Annual Meeting
PNOC Study in Childhood Brain Cancer Enrolls First Patient
Temporary opening of the blood-brain barrier with the nitrone compound OKN-007
Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021
Japan offers new treatment option for brain cancer
Jaime Leandro Foundation treats first cancer patient
Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma
A new treatment for brain tumors available in France (Onc-201)
External Controls to Improve on Glioblastoma Clinical Trials
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2021 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com